Leukocyte Surface Antigen CD47 Market Report

China Leukocyte Surface Antigen CD47 Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 25, 2022
  • PAGES：170
  • REPORT CODE：GMM1163707
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Leukocyte Surface Antigen CD47 market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Leukocyte Surface Antigen CD47 market. Detailed analysis of key players, along with key growth strategies adopted by Leukocyte Surface Antigen CD47 industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Surface Oncology Inc

    • Aurigene Discovery Technologies Ltd

    • Trillium Therapeutics Inc

    • Forty Seven Inc

    • Celgene Corp

    By Type:

    • B-6H12

    • ALX-148

    • CC-90002

    • PSTx-23

    • Others

    By End-User:

    • Lymphoma

    • Ovarian Cancer

    • Ischemia Reperfusion Injury

    • Kindney Transplant Rejection

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Leukocyte Surface Antigen CD47 Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of B-6H12 from 2016 to 2027

    • 1.3.2 China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of ALX-148 from 2016 to 2027

    • 1.3.3 China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of CC-90002 from 2016 to 2027

    • 1.3.4 China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of PSTx-23 from 2016 to 2027

    • 1.3.5 China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of Lymphoma from 2016 to 2027

    • 1.4.2 China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of Ovarian Cancer from 2016 to 2027

    • 1.4.3 China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of Ischemia Reperfusion Injury from 2016 to 2027

    • 1.4.4 China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of Kindney Transplant Rejection from 2016 to 2027

    • 1.4.5 China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Leukocyte Surface Antigen CD47 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Leukocyte Surface Antigen CD47 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Leukocyte Surface Antigen CD47 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Leukocyte Surface Antigen CD47 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Leukocyte Surface Antigen CD47 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Leukocyte Surface Antigen CD47 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Leukocyte Surface Antigen CD47 Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Leukocyte Surface Antigen CD47 Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Leukocyte Surface Antigen CD47 by Major Types

    • 3.4.1 Market Size and Growth Rate of B-6H12

    • 3.4.2 Market Size and Growth Rate of ALX-148

    • 3.4.3 Market Size and Growth Rate of CC-90002

    • 3.4.4 Market Size and Growth Rate of PSTx-23

    • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Leukocyte Surface Antigen CD47 Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Leukocyte Surface Antigen CD47 by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Leukocyte Surface Antigen CD47 in Lymphoma

    • 4.4.2 Market Size and Growth Rate of Leukocyte Surface Antigen CD47 in Ovarian Cancer

    • 4.4.3 Market Size and Growth Rate of Leukocyte Surface Antigen CD47 in Ischemia Reperfusion Injury

    • 4.4.4 Market Size and Growth Rate of Leukocyte Surface Antigen CD47 in Kindney Transplant Rejection

    • 4.4.5 Market Size and Growth Rate of Leukocyte Surface Antigen CD47 in Others

    5 Market Analysis by Regions

    • 5.1 China Leukocyte Surface Antigen CD47 Production Analysis by Regions

    • 5.2 China Leukocyte Surface Antigen CD47 Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Leukocyte Surface Antigen CD47 Landscape Analysis

    • 6.1 North China Leukocyte Surface Antigen CD47 Landscape Analysis by Major Types

    • 6.2 North China Leukocyte Surface Antigen CD47 Landscape Analysis by Major End-Users

    7 Central China Leukocyte Surface Antigen CD47 Landscape Analysis

    • 7.1 Central China Leukocyte Surface Antigen CD47 Landscape Analysis by Major Types

    • 7.2 Central China Leukocyte Surface Antigen CD47 Landscape Analysis by Major End-Users

    8 South China Leukocyte Surface Antigen CD47 Landscape Analysis

    • 8.1 South China Leukocyte Surface Antigen CD47 Landscape Analysis by Major Types

    • 8.2 South China Leukocyte Surface Antigen CD47 Landscape Analysis by Major End-Users

    9 East China Leukocyte Surface Antigen CD47 Landscape Analysis

    • 9.1 East China Leukocyte Surface Antigen CD47 Landscape Analysis by Major Types

    • 9.2 East China Leukocyte Surface Antigen CD47 Landscape Analysis by Major End-Users

    10 Northeast China Leukocyte Surface Antigen CD47 Landscape Analysis

    • 10.1 Northeast China Leukocyte Surface Antigen CD47 Landscape Analysis by Major Types

    • 10.2 Northeast China Leukocyte Surface Antigen CD47 Landscape Analysis by Major End-Users

    11 Southwest China Leukocyte Surface Antigen CD47 Landscape Analysis

    • 11.1 Southwest China Leukocyte Surface Antigen CD47 Landscape Analysis by Major Types

    • 11.2 Southwest China Leukocyte Surface Antigen CD47 Landscape Analysis by Major End-Users

    12 Northwest China Leukocyte Surface Antigen CD47 Landscape Analysis

    • 12.1 Northwest China Leukocyte Surface Antigen CD47 Landscape Analysis by Major Types

    • 12.2 Northwest China Leukocyte Surface Antigen CD47 Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Surface Oncology Inc

      • 13.1.1 Surface Oncology Inc Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Aurigene Discovery Technologies Ltd

      • 13.2.1 Aurigene Discovery Technologies Ltd Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Trillium Therapeutics Inc

      • 13.3.1 Trillium Therapeutics Inc Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Forty Seven Inc

      • 13.4.1 Forty Seven Inc Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Celgene Corp

      • 13.5.1 Celgene Corp Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of B-6H12 from 2016 to 2027

    • Figure China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of ALX-148 from 2016 to 2027

    • Figure China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of CC-90002 from 2016 to 2027

    • Figure China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of PSTx-23 from 2016 to 2027

    • Figure China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of Lymphoma from 2016 to 2027

    • Figure China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of Ovarian Cancer from 2016 to 2027

    • Figure China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of Ischemia Reperfusion Injury from 2016 to 2027

    • Figure China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of Kindney Transplant Rejection from 2016 to 2027

    • Figure China Leukocyte Surface Antigen CD47 Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Leukocyte Surface Antigen CD47 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Leukocyte Surface Antigen CD47 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Leukocyte Surface Antigen CD47 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Leukocyte Surface Antigen CD47 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Leukocyte Surface Antigen CD47 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Leukocyte Surface Antigen CD47 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Leukocyte Surface Antigen CD47 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Leukocyte Surface Antigen CD47 Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Leukocyte Surface Antigen CD47

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Leukocyte Surface Antigen CD47 by Different Types from 2016 to 2027

    • Table Consumption Share of Leukocyte Surface Antigen CD47 by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of B-6H12

    • Figure Market Size and Growth Rate of ALX-148

    • Figure Market Size and Growth Rate of CC-90002

    • Figure Market Size and Growth Rate of PSTx-23

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Leukocyte Surface Antigen CD47 by Different End-Users from 2016 to 2027

    • Table Consumption Share of Leukocyte Surface Antigen CD47 by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Lymphoma

    • Figure Market Size and Growth Rate of Ovarian Cancer

    • Figure Market Size and Growth Rate of Ischemia Reperfusion Injury

    • Figure Market Size and Growth Rate of Kindney Transplant Rejection

    • Figure Market Size and Growth Rate of Others

    • Table China Leukocyte Surface Antigen CD47 Production by Regions

    • Table China Leukocyte Surface Antigen CD47 Production Share by Regions

    • Figure China Leukocyte Surface Antigen CD47 Production Share by Regions in 2016

    • Figure China Leukocyte Surface Antigen CD47 Production Share by Regions in 2021

    • Figure China Leukocyte Surface Antigen CD47 Production Share by Regions in 2027

    • Table China Leukocyte Surface Antigen CD47 Consumption by Regions

    • Table China Leukocyte Surface Antigen CD47 Consumption Share by Regions

    • Figure China Leukocyte Surface Antigen CD47 Consumption Share by Regions in 2016

    • Figure China Leukocyte Surface Antigen CD47 Consumption Share by Regions in 2021

    • Figure China Leukocyte Surface Antigen CD47 Consumption Share by Regions in 2027

    • Table North China Leukocyte Surface Antigen CD47 Consumption by Types from 2016 to 2027

    • Table North China Leukocyte Surface Antigen CD47 Consumption Share by Types from 2016 to 2027

    • Figure North China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2016

    • Figure North China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2021

    • Figure North China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2027

    • Table North China Leukocyte Surface Antigen CD47 Consumption by End-Users from 2016 to 2027

    • Table North China Leukocyte Surface Antigen CD47 Consumption Share by End-Users from 2016 to 2027

    • Figure North China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2016

    • Figure North China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2021

    • Figure North China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2027

    • Table Central China Leukocyte Surface Antigen CD47 Consumption by Types from 2016 to 2027

    • Table Central China Leukocyte Surface Antigen CD47 Consumption Share by Types from 2016 to 2027

    • Figure Central China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2016

    • Figure Central China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2021

    • Figure Central China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2027

    • Table Central China Leukocyte Surface Antigen CD47 Consumption by End-Users from 2016 to 2027

    • Table Central China Leukocyte Surface Antigen CD47 Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2016

    • Figure Central China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2021

    • Figure Central China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2027

    • Table South China Leukocyte Surface Antigen CD47 Consumption by Types from 2016 to 2027

    • Table South China Leukocyte Surface Antigen CD47 Consumption Share by Types from 2016 to 2027

    • Figure South China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2016

    • Figure South China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2021

    • Figure South China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2027

    • Table South China Leukocyte Surface Antigen CD47 Consumption by End-Users from 2016 to 2027

    • Table South China Leukocyte Surface Antigen CD47 Consumption Share by End-Users from 2016 to 2027

    • Figure South China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2016

    • Figure South China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2021

    • Figure South China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2027

    • Table East China Leukocyte Surface Antigen CD47 Consumption by Types from 2016 to 2027

    • Table East China Leukocyte Surface Antigen CD47 Consumption Share by Types from 2016 to 2027

    • Figure East China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2016

    • Figure East China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2021

    • Figure East China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2027

    • Table East China Leukocyte Surface Antigen CD47 Consumption by End-Users from 2016 to 2027

    • Table East China Leukocyte Surface Antigen CD47 Consumption Share by End-Users from 2016 to 2027

    • Figure East China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2016

    • Figure East China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2021

    • Figure East China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2027

    • Table Northeast China Leukocyte Surface Antigen CD47 Consumption by Types from 2016 to 2027

    • Table Northeast China Leukocyte Surface Antigen CD47 Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2016

    • Figure Northeast China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2021

    • Figure Northeast China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2027

    • Table Northeast China Leukocyte Surface Antigen CD47 Consumption by End-Users from 2016 to 2027

    • Table Northeast China Leukocyte Surface Antigen CD47 Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2016

    • Figure Northeast China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2021

    • Figure Northeast China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2027

    • Table Southwest China Leukocyte Surface Antigen CD47 Consumption by Types from 2016 to 2027

    • Table Southwest China Leukocyte Surface Antigen CD47 Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2016

    • Figure Southwest China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2021

    • Figure Southwest China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2027

    • Table Southwest China Leukocyte Surface Antigen CD47 Consumption by End-Users from 2016 to 2027

    • Table Southwest China Leukocyte Surface Antigen CD47 Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2016

    • Figure Southwest China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2021

    • Figure Southwest China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2027

    • Table Northwest China Leukocyte Surface Antigen CD47 Consumption by Types from 2016 to 2027

    • Table Northwest China Leukocyte Surface Antigen CD47 Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2016

    • Figure Northwest China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2021

    • Figure Northwest China Leukocyte Surface Antigen CD47 Consumption Share by Types in 2027

    • Table Northwest China Leukocyte Surface Antigen CD47 Consumption by End-Users from 2016 to 2027

    • Table Northwest China Leukocyte Surface Antigen CD47 Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2016

    • Figure Northwest China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2021

    • Figure Northwest China Leukocyte Surface Antigen CD47 Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Surface Oncology Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Surface Oncology Inc

    • Figure Sales and Growth Rate Analysis of Surface Oncology Inc

    • Figure Revenue and Market Share Analysis of Surface Oncology Inc

    • Table Product and Service Introduction of Surface Oncology Inc

    • Table Company Profile and Development Status of Aurigene Discovery Technologies Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurigene Discovery Technologies Ltd

    • Figure Sales and Growth Rate Analysis of Aurigene Discovery Technologies Ltd

    • Figure Revenue and Market Share Analysis of Aurigene Discovery Technologies Ltd

    • Table Product and Service Introduction of Aurigene Discovery Technologies Ltd

    • Table Company Profile and Development Status of Trillium Therapeutics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Trillium Therapeutics Inc

    • Figure Sales and Growth Rate Analysis of Trillium Therapeutics Inc

    • Figure Revenue and Market Share Analysis of Trillium Therapeutics Inc

    • Table Product and Service Introduction of Trillium Therapeutics Inc

    • Table Company Profile and Development Status of Forty Seven Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Forty Seven Inc

    • Figure Sales and Growth Rate Analysis of Forty Seven Inc

    • Figure Revenue and Market Share Analysis of Forty Seven Inc

    • Table Product and Service Introduction of Forty Seven Inc

    • Table Company Profile and Development Status of Celgene Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corp

    • Figure Sales and Growth Rate Analysis of Celgene Corp

    • Figure Revenue and Market Share Analysis of Celgene Corp

    • Table Product and Service Introduction of Celgene Corp


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US